Skip navigation

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy

Turner, John J. D., Parrott, Andrew C., Goodwin, Julia, Moore, Derek G., Fulton, Sarah, Min, Meeyoung O. and Singer, Lynn T. (2013) Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy. Journal of Psychopharmacology, 28 (1). pp. 55-61. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/0269881113515061)

[img]
Preview
PDF (Author Accepted Manuscript)
19922 MOORE_Psychiatric_Profiles_of_Mothers_who_Take_Ecstacy_During_Pregnancy_2013.pdf - Accepted Version

Download (239kB) | Preview

Abstract

Background:
The recreational drug MDMA (3,4-methylenedioxymethamphetamine) or ‘Ecstasy’ is associated with heightened psychiatric distress and feelings of depression. The Drugs and Infancy Study (DAISY) monitored the psychiatric symptom profiles of mothers who used Ecstasy/MDMA while pregnant, and followed them over the first year post-partum.

Methods:
We compared 28 young women whom took MDMA during their pregnancy with a polydrug control group of 68 women who took other psychoactive drugs while pregnant. The Brief Symptom Inventory (BSI) was completed for several periods: The first trimester of pregnancy; and 1, 4 and 12 months after childbirth. Recreational drug use was monitored at each time point.

Results:
During the first trimester of pregnancy, MDMA-using mothers reported higher depression scores than the polydrug controls. At 1 year after childbirth, their BSI depression scores were significantly lower, now closer to the control group values. At the same time point, their self-reported use of MDMA became nearly zero, in contrast to their continued use of Cannabis/marijuana, nicotine and alcohol. We found significant symptom reductions in those with BSI obsessive-compulsive and interpersonal sensitivity, following Ecstasy/MDMA cessation.

Conclusions:
The findings from this unique prospective study of young recreational drug-using mothers are consistent with previous reports of improved psychiatric health after quitting MDMA.

Item Type: Article
Uncontrolled Keywords: Drugs; MDMA infants; outcomes; maternal depression
Faculty / Department / Research Group: Faculty of Education & Health
Faculty of Education & Health > Applied Psychology Research Group
Last Modified: 04 Jun 2018 10:38
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: GREAT a
Selected for GREAT 2019: None
URI: http://gala.gre.ac.uk/id/eprint/19922

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics